Silent Existence of Eosinopenia in Sepsis: a Systematic Review and Meta-analysis

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2021 May 25

PMID 34030641

Citations 13

Authors

Yao Lin

Jiabing Rong

Zhaocai Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Sepsis is a life-threatening and time-critical medical emergency; therefore, the early diagnosis of sepsis is essential to timely treatment and favorable outcomes for patients susceptible to sepsis. Eosinopenia has been identified as a potential biomarker of sepsis in the past decade. However, its clinical application progress is slow and its recognition is low. Recent studies have again focused on the potential association between Eosinopenia and severe infections. This study analyzed the efficacy of Eosinopenia as a biomarker for diagnosis of sepsis and its correlation with pathophysiology of sepsis.

Method: The protocol for this meta-analysis is available in PROSPERO (CRD42020197664). We searched PubMed, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials CENTRAL databases to identify studies that met the inclusion criteria. Two authors performed data extraction independently. The pooled outcomes were calculated by TP (true positive), FP (false positive), FN (false negative), TN (true negative) by using bivariate meta-analysis model in STATA 14.0 software. Meanwhile, possible mechanisms of sepsis induced Eosinopenia was also analyzed.

Results: Seven studies were included in the present study with a total number of 3842 subjects. The incidence of Eosinopenia based on the enrolled studies varied from 23.2 to 92.7%. For diagnosis of sepsis, the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio of Eosinopenia were 0.66 (95%CI [0.53-0.77]), 0.68 (95%CI [0.56-0.79]), 2.09 (95%CI [1.44-3.02]), 0.49 (95%CI [0.34-0.71]) and 4.23 (95%CI [2.15-8.31]), respectively. The area under the summary receiver operator characteristic curve (SROC) was 0.73 (95%CI [0.68-0.76]). Meta-regression analysis revealed that no single parameter accounted for the heterogeneity of pooled outcomes. For each subgroup of different eosinopenia cutoff values (50, 40, ≤25, 100), the sensitivity was 0.61, 0.79, 0.57, 0.54, and the specificity was 0.61, 0.75, 0.83, 0.51, respectively.

Conclusions: Our findings suggested that Eosinopenia has a high incidence in sepsis but has no superiority in comparison with conventional biomarkers for diagnosis of sepsis. However, eosinopenia can still be used in clinical diagnosis for sepsis as a simple, convenient, fast and inexpensive biomarker. Therefore, further large clinical trials are still needed to re-evaluate eosinopenia as a biomarker of sepsis.

Citing Articles

Eosinopenia as a predictor of clinical outcomes in hospitalized patients with community-acquired pneumonia: A retrospective cohort study.

Farah W, Wang Z, Gajic O, Odeyemi Y PLoS One. 2025; 20(3):e0314336.

PMID: 40048439 PMC: 11884692. DOI: 10.1371/journal.pone.0314336.

The Role of Monocyte Distribution Width (MDW) in the Prediction of Death in Adult Patients with Sepsis.

Theodoridis D, Tsifi A, Magiorkinis E, Tsamakidis X, Voulgaridis A, Moustaferi E Microorganisms. 2025; 13(2).

PMID: 40005792 PMC: 11858437. DOI: 10.3390/microorganisms13020427.

Immune regulation and organ damage link adiponectin to sepsis.

Zhang L, Lin Y, Zhang Z, Chen Y, Zhong J Front Immunol. 2024; 15:1444884.

PMID: 39664383 PMC: 11632310. DOI: 10.3389/fimmu.2024.1444884.

Platelet Metabolites as Candidate Biomarkers in Sepsis Diagnosis and Management Using the Proposed Explainable Artificial Intelligence Approach.

Yagin F, Aygun U, Algarni A, Colak C, Al-Hashem F, Ardigo L J Clin Med. 2024; 13(17).

PMID: 39274215 PMC: 11395774. DOI: 10.3390/jcm13175002.

High rates of mood disorders in patients with chronic idiopathic eosinopenia.

Magen E, Geishin A, Weizman A, Merzon E, Green I, Magen I Brain Behav Immun Health. 2024; 40:100847.

PMID: 39252984 PMC: 11381620. DOI: 10.1016/j.bbih.2024.100847.

References

Reinhart K, Daniels R, Kissoon N, Machado F, Schachter R, Finfer S . Recognizing Sepsis as a Global Health Priority - A WHO Resolution. N Engl J Med. 2017; 377(5):414-417. DOI: 10.1056/NEJMp1707170. View

Whiting P, Rutjes A, Westwood M, Mallett S, Deeks J, Reitsma J . QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155(8):529-36. DOI: 10.7326/0003-4819-155-8-201110180-00009. View

Bass D, Gonwa T, Szejda P, Cousart M, Dechatelet L, McCall C . Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest. 1980; 65(6):1265-71. PMC: 371463. DOI: 10.1172/JCI109789. View

Lavoignet C, Le Borgne P, Slimani H, Forato M, Kam C, Kauffmann P . [Relevance of eosinopenia as marker of sepsis in the Emergency Department]. Rev Med Interne. 2016; 37(11):730-734. DOI: 10.1016/j.revmed.2016.02.018. View

Gil H, Magy N, Mauny F, Dupond J . [Value of eosinopenia in inflammatory disorders: an "old" marker revisited]. Rev Med Interne. 2003; 24(7):431-5. DOI: 10.1016/s0248-8663(03)00138-3. View

Anand D, Ray S, Bhargava S, Srivastava L, Garg A, Gafoor I . Exploration of eosinopenia as a diagnostic parameter to differentiate sepsis from systemic inflammatory response syndrome: Results from an observational study. Indian J Crit Care Med. 2016; 20(5):285-90. PMC: 4876650. DOI: 10.4103/0972-5229.182199. View

Li Q, Ding X, Xia G, Chen H, Chen F, Geng Z . Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control study. EClinicalMedicine. 2020; 23:100375. PMC: 7196382. DOI: 10.1016/j.eclinm.2020.100375. View

Jesenak M, Brndiarova M, Urbancikova I, Rennerova Z, Vojtkova J, Bobcakova A . Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis. Front Cell Infect Microbiol. 2020; 10:364. PMC: 7338601. DOI: 10.3389/fcimb.2020.00364. View

Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y . Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75(7):1730-1741. DOI: 10.1111/all.14238. View

10.

Lopez de Toro Martin Consuegra I, Sanchez Casado M, Rodriguez Villar S, Raigal Cano A, Lopez Reina Torrijos P, Velasco Ramos A . [Evaluation of eosinopenia as an infection marker in critical care patients]. Med Intensiva. 2010; 34(4):246-53. DOI: 10.1016/j.medin.2009.11.007. View

11.

Bass D . Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest. 1975; 56(4):870-9. PMC: 301942. DOI: 10.1172/JCI108166. View

12.

Xu G, Yang Y, Du Y, Peng F, Hu P, Wang R . Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice. Clin Rev Allergy Immunol. 2020; 59(1):89-100. PMC: 7180681. DOI: 10.1007/s12016-020-08792-8. View

13.

Chusid M . Eosinophils: Friends or Foes?. J Allergy Clin Immunol Pract. 2018; 6(5):1439-1444. DOI: 10.1016/j.jaip.2018.04.031. View

14.

Merino C, Martinez F, Cardemil F, Rodriguez J . Absolute eosinophils count as a marker of mortality in patients with severe sepsis and septic shock in an intensive care unit. J Crit Care. 2011; 27(4):394-9. DOI: 10.1016/j.jcrc.2011.10.010. View

15.

Lavoignet C, Le Borgne P, Chabrier S, Bidoire J, Slimani H, Chevrolet-Lavoignet J . White blood cell count and eosinopenia as valuable tools for the diagnosis of bacterial infections in the ED. Eur J Clin Microbiol Infect Dis. 2019; 38(8):1523-1532. DOI: 10.1007/s10096-019-03583-2. View

16.

Garnacho-Montero J, Huici-Moreno M, Gutierrez-Pizarraya A, Lopez I, Marquez-Vacaro J, Macher H . Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis. Crit Care. 2014; 18(3):R116. PMC: 4229882. DOI: 10.1186/cc13908. View

17.

Carlson T, Endres B, Le Pham J, Gonzales-Luna A, Alnezary F, Nebo K . Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Infection. Open Forum Infect Dis. 2020; 7(1):ofz552. PMC: 6979314. DOI: 10.1093/ofid/ofz552. View

18.

Lindsley A, Schwartz J, Rothenberg M . Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020; 146(1):1-7. PMC: 7194727. DOI: 10.1016/j.jaci.2020.04.021. View

19.

Carrigan S, Scott G, Tabrizian M . Toward resolving the challenges of sepsis diagnosis. Clin Chem. 2004; 50(8):1301-14. DOI: 10.1373/clinchem.2004.032144. View

20.

Shaaban H, Daniel S, Sison R, Slim J, Perez G . Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?. J Crit Care. 2010; 25(4):570-5. DOI: 10.1016/j.jcrc.2010.03.002. View